Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization

被引:9
|
作者
Javaid, Nida [1 ,2 ]
Olwagen, Courtney [3 ,4 ]
Nzenze, Susan [3 ,4 ]
Hawkins, Paulina [5 ]
Gladstone, Rebecca [2 ]
McGee, Lesley [5 ]
Breiman, Robert F. [6 ]
Bentley, Stephen D. [2 ,7 ]
Madhi, Shabir A. [3 ,4 ]
Lo, Stephanie [2 ]
机构
[1] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[2] Wellcome Sanger Inst, Parasites & Microbes, Hinxton, England
[3] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa
[4] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Emory Global Hlth Inst, Atlanta, GA USA
[7] Univ Cambridge, Dept Pathol, Cambridge, England
来源
MICROBIAL GENOMICS | 2022年 / 8卷 / 06期
关键词
antimicrobial resistance; pneumococci; pneumococcal carriage; pneumococcal conjugate vaccine; pneumococcal genomics; TEMPORAL-CHANGES; COLONIZATION; DISEASE;
D O I
10.1099/mgen.0.000831
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Streptococcus pneumoniae is a major human pathogen responsible for over 317000 deaths in children <5 years of age with the burden of the disease being highest in low-and middle-income countries including South Africa. Following the introduction of the 7-valent and 13-valent pneumococcal conjugate vaccine (PCV) in South Africa in 2009 and 2011, respectively, a decrease in both invasive pneumococcal infections and asymptomatic carriage of vaccine -type pneumococci were reported. In this study, we described the changing epidemiology of the pneumococcal carriage population in South Africa, by sequencing the genomes of 1825 isolates collected between 2009 and 2013. Using these genomic data, we reported the changes in serotypes, Global Pneumococ-cal Sequence Clusters (GPSCs), and antibiotic resistance before and after the introduction of PCV13. The pneumococcal carriage population in South Africa has a high level of diversity, comprising of 126 GPSCs and 49 serotypes. Of the ten most prevalent GPSCs detected, six were predominantly found in Africa (GPSC22, GPSC21, GPSC17, GPSC33, GPSC34 and GPSC52). We found a significant decrease in PCV7 serotypes (19F, 6B, 23F and 14) and an increase in non-vaccine serotypes (NVT) (16F, 34, 35B and 11A) among children <2 years of age. The increase in NVTs was driven by pneumococcal lineages GPSC33, GPSC34, GPSC5 and GPSC22. Overall, a decrease in antibiotic resistance for 11 antimicrobials was detected in the PCV13 era. Further, we reported a higher resistance prevalence among vaccine types (VTs), as compared to NVTs; however, an increase in penicillin resistance among NVT was observed between the PCV7 and PCV13 eras. The carriage isolates from South Africa predominantly belonged to pneumococcal lineages, which are endemic to Africa. While the introduction of PCV resulted in an overall reduction of resistance in pneumococcal carriage isolates, an increase in penicillin resistance among NVTs was detected in children aged between 3 and 5 years, driven by the expan-sion of penicillin-resistant clones associated with NVTs in the PCV13 era.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
    Mark Atwood
    Linda Beausoleil
    Marie-Claude Breton
    Craig Laferriere
    Reiko Sato
    Derek Weycker
    Canadian Journal of Public Health, 2018, 109 : 756 - 768
  • [32] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants
    Perdrizet, Johnna
    Horn, Emily K.
    Nua, Winniefer
    Perez-Peralta, Judith
    Nailes, Jennifer
    Santos, Jaime
    Ong-Lim, Anna
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2625 - 2642
  • [33] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants
    Rajeev Dhere
    Vistasp Sethna
    Hitesh Malviya
    Rajeshwari Adhiseshan
    Infectious Diseases and Therapy, 2022, 11 : 1297 - 1299
  • [34] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants
    Johnna Perdrizet
    Emily K. Horn
    Winniefer Nua
    Judith Perez-Peralta
    Jennifer Nailes
    Jaime Santos
    Anna Ong-Lim
    Infectious Diseases and Therapy, 2021, 10 : 2625 - 2642
  • [35] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants
    Dhere, Rajeev
    Sethna, Vistasp
    Malviya, Hitesh
    Adhiseshan, Rajeshwari
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (03) : 1297 - 1299
  • [36] Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States
    Jacobs, David M.
    Yung, Francine
    Hart, Emily
    Nguyen, Melanie N. H.
    Shaver, Amy
    VACCINE, 2017, 35 (45) : 6160 - 6165
  • [37] Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
    Garcia Garrido, Hannah M.
    Vollaard, Albert
    D'Haens, Geert R.
    Spuls, Phyllis I.
    Bemelman, Frederike J.
    Tanck, Michael W.
    de Bree, Godelieve J.
    Meek, Bob
    Grobusch, Martin P.
    Goorhuis, Abraham
    VACCINES, 2022, 10 (05)
  • [38] Improving Pneumococcal 13-valent Conjugate (PCV13) Vaccination Rates and Physician Documentation in the Geriatrics Clinic
    Sheikh, A.
    Phillips, S. C.
    Scott-Iriarte, S.
    Pravodelov, V.
    Lee, W.
    Jang, A.
    Pearse, M.
    Reaves, J.
    Tran, N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S167 - S167
  • [39] Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13
    Mitchell, Patrick K.
    Azarian, Taj
    Croucher, Nicholas J.
    Callendrello, Alanna
    Thompson, Claudette M.
    Pelton, Stephen, I
    Lipsitch, Marc
    Hanage, William P.
    MICROBIAL GENOMICS, 2019, 5 (02):
  • [40] CALCULATING THE INDIRECT COSTS OF ADULT PNEUMOCOCCAL DISEASE AND THE RATE OF RETURN TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN OLDER ADULTS, WITH AN APPLICATION TO DENMARK
    Sevilla, J. P.
    Stawasz, A.
    Bumes, D.
    Poulsen, P. B.
    Sato, R.
    Bloom, D. E.
    VALUE IN HEALTH, 2017, 20 (09) : A787 - A787